Cargando…

Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies

The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yang, Wang, Meiqi, Liu, Dan, Ullah, Saif, Ma, Xing, Yang, Huiyu, Liu, Bingrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647064/
https://www.ncbi.nlm.nih.gov/pubmed/36387198
http://dx.doi.org/10.3389/fonc.2022.1036648
_version_ 1784827303100940288
author Shi, Yang
Wang, Meiqi
Liu, Dan
Ullah, Saif
Ma, Xing
Yang, Huiyu
Liu, Bingrong
author_facet Shi, Yang
Wang, Meiqi
Liu, Dan
Ullah, Saif
Ma, Xing
Yang, Huiyu
Liu, Bingrong
author_sort Shi, Yang
collection PubMed
description The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomic regulatory entity in close genomic proximity, are underpinned by control cancer cell identity. As a consequence, the transcriptional addictions driven by SEs could offer an Achilles’ heel for molecular treatments on patients of esophageal carcinoma and other types of cancer as well. In this review, we summarize the recent findings about the oncogenic SEs upon which esophageal cancer cells depend, and discuss why SEs could be seen as the hallmark of cancer, how transcriptional dependencies driven by SEs, and what opportunities could be supplied based on this cancer-specific SEs.
format Online
Article
Text
id pubmed-9647064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96470642022-11-15 Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies Shi, Yang Wang, Meiqi Liu, Dan Ullah, Saif Ma, Xing Yang, Huiyu Liu, Bingrong Front Oncol Oncology The tumorigenesis of esophageal carcinoma arises from transcriptional dysregulation would become exceptionally dependent on specific regulators of gene expression, which could be preferentially attributed to the larger non-coding cis-regulatory elements, i.e. super-enhancers (SEs). SEs, large genomic regulatory entity in close genomic proximity, are underpinned by control cancer cell identity. As a consequence, the transcriptional addictions driven by SEs could offer an Achilles’ heel for molecular treatments on patients of esophageal carcinoma and other types of cancer as well. In this review, we summarize the recent findings about the oncogenic SEs upon which esophageal cancer cells depend, and discuss why SEs could be seen as the hallmark of cancer, how transcriptional dependencies driven by SEs, and what opportunities could be supplied based on this cancer-specific SEs. Frontiers Media S.A. 2022-10-27 /pmc/articles/PMC9647064/ /pubmed/36387198 http://dx.doi.org/10.3389/fonc.2022.1036648 Text en Copyright © 2022 Shi, Wang, Liu, Ullah, Ma, Yang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shi, Yang
Wang, Meiqi
Liu, Dan
Ullah, Saif
Ma, Xing
Yang, Huiyu
Liu, Bingrong
Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title_full Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title_fullStr Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title_full_unstemmed Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title_short Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
title_sort super-enhancers in esophageal carcinoma: transcriptional addictions and therapeutic strategies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647064/
https://www.ncbi.nlm.nih.gov/pubmed/36387198
http://dx.doi.org/10.3389/fonc.2022.1036648
work_keys_str_mv AT shiyang superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT wangmeiqi superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT liudan superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT ullahsaif superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT maxing superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT yanghuiyu superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies
AT liubingrong superenhancersinesophagealcarcinomatranscriptionaladdictionsandtherapeuticstrategies